Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cardiol Therapeutics's market cap was $87.86M on Nov 11, 2026, against $75.15M a year earlier. Over the last 5 years it ranged from $22.04M to $171.80M, with a median of $75.15M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $87.86M | +28.7% |
| 2025 | Dec 31, 2025 | $68.26M | -17.3% |
| 2024 | Dec 31, 2024 | $82.51M | +56.6% |
| 2023 | Dec 29, 2023 | $52.71M | +139.1% |
| 2022 | Dec 30, 2022 | $22.04M | -60.1% |
| 2021 | Dec 31, 2021 | $55.24M | – |
See a number that looks wrong?